ClariVest Asset Management’s Kyntra Bio KYNB Stock Holding History
Bought
Maintained
Sold
Other funds holding KYNB
HA
ClariVest Asset Management's KYNB Position: Q2 2021 in Review
ClariVest Asset Management sold out of Kyntra Bio (KYNB) in Q2 2021, closing a stake of 2,279 shares — an estimated $1.98M sold.
ClariVest Asset Management first reported a position in KYNB in Q1 2017 and held it in 17 quarters. The position peaked at $3.31M in Q3 2020. 174 funds tracked by Wall St. Rank hold KYNB as of Q2 2021.
- ClariVest Asset Management reported no remaining Kyntra Bio position as of Q2 2021 after selling out during the quarter.
- ClariVest Asset Management sold 2,279 Kyntra Bio shares in Q2 2021, an estimated $1.98M.
- ClariVest Asset Management first reported a position in Kyntra Bio in Q1 2017 and held it in 17 quarters.
- ClariVest Asset Management's Kyntra Bio position peaked at $3.31M in Q3 2020.
- 174 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2021.
Based on ClariVest Asset Management's 13F filing for Q2 2021, filed 9 Aug 2021.